Crysforma provides complete scientific support for the discovery, analysis and scale-up of polymorphs, hydrates, amorphous phases, salts and co-crystals of active pharmaceutical ingredients or intermediates.
Crysforma has developed its own crystallization screening methodology based on the combination of several crystallization procedures. We use high-throughput crystallization systems controlled by highly skilled scientists to maximize the information drawn from each experiment.
Our projects are always carried out in close collaboration with the client, adapted to the customer's needs and under strict confidentiality conditions. Crysforma is a technology development unit belonging to the Institute of Chemical research of Catalonia (ICIQ).
Company Details
- Employees
- 6
- Address
- Av Països Catalans 16, Tarragona,43002,spain
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- crysforma.com
- Keywords
- crystallization, polymorphism, pharmaceutical salt, co-crystal, cocrystal, polymorph, polymorph API, API, pharmaceutical solid state.
- HQ
- Tarragona
Crysforma Questions
Crysforma's website is crysforma.com
Crysforma's LinkedIn profile is https://es.linkedin.com/company/crysforma
Crysforma has
6 employees.
View email and phone details for 6
employees at Crysforma.
Crysforma's industry is
Pharmaceutical Manufacturing
Crysforma's top competitors are
Nice Tech,
Bcn Peptides,
Farmhispania Group,
Timup,
Catsci Ltd,
Triclinic Labs, Llc.,
Ameca Sa - Fastening Solutions,
Gp-Pharm,
Agrofresh,
Grupo Vall Companys.
Crysforma's categories are Pharmaceutical Manufacturing
